The synergistic effects of betanin and radiotherapy in a prostate cancer cell line: an in vitro study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Wang L et al (2022) Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health 10:811044
Baskar R et al (2012) Cancer and radiation therapy: current advances and future directions. Int J Med Sci 9(3):193
Tomioka A et al (2008) Delivery of PTEN via a novel gene microcapsule sensitizes prostate cancer cells to irradiation. Mol Cancer Ther 7(7):1864–1870
Fang Y, DeMarco VG, Nicholl MB (2012) Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci 103(6):1090–1098
Vaupel P (2004) Tumor microenvironmental physiology and its implications for radiation oncology. In seminars in radiation oncology. Elsevier
Krajka-Kuźniak V et al (2013) Betanin, a beetroot component, induces nuclear factor erythroid-2-related factor 2-mediated expression of detoxifying/antioxidant enzymes in human liver cell lines. Br J Nutr 110(12):2138–2149
Ahmadian E et al (2018) Betanin reduces organophosphate induced cytotoxicity in primary hepatocyte via an anti-oxidative and mitochondrial dependent pathway. Pestic Biochem Physiol 144:71–78
Georgiev VG et al (2010) Antioxidant activity and phenolic content of betalain extracts from intact plants and hairy root cultures of the red beetroot Beta vulgaris cv. Detroit dark red. Plant Foods Hum Nutr 65:105–111
Azeredo HM (2009) Betalains: properties, sources, applications, and stability–a review. Int J Food Sci Technol 44(12):2365–2376
Eftekhari A et al (2020) Hepatoprotective role of berberine against paraquat-induced liver toxicity in rat. Environ Science and Pollution Research 27:4969–4975.
Silva DVTd et al (2021) Betanin as a multipath oxidative stress and inflammation modulator: a beetroot pigment with protective effects on cardiovascular disease pathogenesis. Crit Rev Food Sci Nutr 62(2):539–554
Kazimierczak R et al (2014) Beetroot (Beta vulgaris L.) and naturally fermented beetroot juices from organic and conventional production: metabolomics, antioxidant levels and anticancer activity. J Sci Food Agric 94(13):2618–2629
Lechner JF, Stoner GD (2019) Red beetroot and betalains as cancer chemopreventative agents. Molecules 24(8):1602
Zoi V et al (2021) Curcumin and radiotherapy exert synergistic anti-glioma effect in vitro. Biomedicines 9(11):1562
Jafari S et al (2023) Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines. Clin Transl Oncol, : p. 1–10
Chou T-C (2018) The combination index (CI < 1) as the definition of synergism and of synergy claims. Elsevier, pp 49–50
Cojoc M et al (2015) Aldehyde dehydrogenase is regulated by β-Catenin/TCF and promotes Radioresistance in prostate Cancer progenitor CellsALDH1 is a marker of prostate Cancer Radioresistance. Cancer Res 75(7):1482–1494
Schulz A et al (2019) Cancer stem cells and radioresistance: DNA repair and beyond. Cancers 11(6):862
Shimura T et al (2014) AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells. Radiother Oncol 112(2):302–307
Chang L et al (2014) PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways. Cell Death Dis 5(10):e1437–e1437
Tang Q et al (2018) Genistein and AG1024 synergistically increase the radiosensitivity of prostate cancer cells. Oncol Rep 40(2):579–588
Manjunath M, Choudhary B (2021) Triple–negative breast cancer: a run–through of features, classification and current therapies. Oncol Lett 22(1):1–21
Zhang Q-Y et al (2018) Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol 9:1253
Xu L et al (2018) Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms. Pharmacol Res 130:451–465
Gullo VP et al (2006) Drug discovery from natural products. J Ind Microbiol Biotechnol 33(7):523–531
Clifford T et al (2015) The potential benefits of red beetroot supplementation in health and disease. Nutrients 7(4):2801–2822
Chhikara N et al (2019) Bioactive compounds of beetroot and utilization in food processing industry: a critical review. Food Chem 272:192–200
Wruss J et al (2015) Compositional characteristics of commercial beetroot products and beetroot juice prepared from seven beetroot varieties grown in Upper Austria. J Food Compos Anal 42:46–55
Paluszczak J, Krajka-Kuźniak V, Baer-Dubowska W (2010) The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol Lett 192(2):119–125
Shafreen M, Kumar N (2022) Inhibition of Proliferation in Ovarian Cancer Cell Line (PA-1) by the action of green compound betanin. Appl Biochem Biotechnol 194(1):71–83
Mancini MCS et al (2021) Beetroot and leaf extracts present protective effects against prostate cancer cells, inhibiting cell proliferation, migration, and growth signaling pathways. Phytother Res 35(9):5241–5258
Kapadia GJ et al (2013) Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines. J Complement Integr Med 10(1):113–122
Hennequin C, Guillerm S, Quero L (2019) Combination of chemotherapy and radiotherapy: a thirty years evolution. Cancer/Radiothérapie 23(6–7):662–665
Bernal-Estévez D et al (2016) Chemotherapy and radiation therapy elicits tumor specific T cell responses in a breast cancer patient. BMC Cancer 16:1–13
Saber A et al (2021) Antiproliferative and Apoptotic Effects of Red Beetroot and Betanin on Human Colorectal Cancer Cell Lines
Salimi A et al (2021) Evaluation of cytotoxic activity of betanin against U87MG human glioma cells and normal human lymphocytes and its anticancer potential through mitochondrial pathway. Nutr Cancer 73(3):450–459
Zhang Q et al (2013) Beetroot red (betanin) inhibits vinyl carbamate-and benzo (a) pyrene‐induced lung tumorigenesis through apoptosis. Mol Carcinog 52(9):686–691
Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26(9):1324–1337
Scopa CD et al (2001) bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer. Appl Immunohistochem Mol Morphology 9(4):329–334
Rosser CJ et al (2003) Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma. Int J Radiation Oncology* Biology* Phys 56(1):1–6
An J et al (2007) Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor. Oncogene 26(5):652–661
Ezekwudo D et al (2008) Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate. Cancer Lett 270(2):277–285
Anai S et al (2007) Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization. Urology 70(4):832–837
Al-Rasheed N et al (2017) Amelioration of panadol-induced nephrotoxicity via down-regulation of Bax/Bcl2 ratio with some antioxidants. Pharmacol Rep 69:1088–1093
Karimian A, Ahmadi Y, Yousefi B (2016) Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair 42:63–71
Kuang Y et al (2021) Multiple functions of p21 in cancer radiotherapy. J Cancer Res Clin Oncol 147:987–1006
Zhang M et al (2010) Inhibition of p21-activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cells. Prostate 70(8):807–816